# INVIRASE
> **NDA021785** · New Drug Application · Sponsor: HOFFMANN-LA ROCHE · Approved 2004-12-17
## Drug
- **FDA Application Number:** NDA021785
- **Application type:** New Drug Application
- **Brand name:** INVIRASE
- **Generic name:** Saquinavir Mesylate
- **Active ingredients:** SAQUINAVIR MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HOFFMANN-LA ROCHE
- **First approval:** 2004-12-17
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021785)
---
*AI Analytics · CC0 1.0*